Implantable ventricular assist devices are mechanical pumps that control and regulate the blood flow from ventricles of heart to the rest of body. These devices replicate the functioning of ventricles and implanted at the lower end of heart. These devices are implanted when ventricles fail to perform their function due to various medical conditions such as bundle branch block, and myocardial infection. They are either implanted for small period or lifelong to treat the heart rate. In addition, they are also used as temporary implants until the heart transplant is performed.
MARKET DYNAMICS
The implantable ventricular assist devices market is driving due to the increasing prevalence of cardiovascular disorders, mainly hypertension, ventricular septal defect, heart failure, and stroke. However, risk associated with its implantation such as development of blood clots, respiratory failure and device failure is expected to hamper the growth of the global implantable ventricular assist devices market. Moreover, technological advancements with regard to the advanced features such as infection control technology is anticipated to drive demand the growth of the market.
MARKET SCOPE
The "Implantable Ventricular Assist Devices Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of implantable ventricular assist devices market with detailed market segmentation by product and application. The implantable ventricular assist devices market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in implantable ventricular assist devices market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The implantable ventricular assist devices market is segmented on the basis of product, and application. On the basis of product, the market is segmented into left ventricular assist device (LVAD), right ventricular assist device (RVAD), biventricular assist device (BiVAD), and total artificial heart (TAH). Based on application, the market is segmented into bridge-to-transplant (BTT) therapy, destination therapy, and other therapies.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the implantable ventricular assist devices market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The implantable ventricular assist devices market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting implantable ventricular assist devices market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the implantable ventricular assist devices market in these regions.
MARKET PLAYERS
The report covers key developments in the implantable ventricular assist devices market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from implantable ventricular assist devices market are anticipated to have lucrative growth opportunities in the future with the rising demand for implantable ventricular assist devices market in the global market. Below mentioned is the list of few companies engaged in the implantable ventricular assist devices market.
The report also includes the profiles of key players in implantable ventricular assist devices market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- ABIOMED
- BiVACOR Inc.
- Abbott
- Medtronic
- Terumo Europe NV
- Berlin Heart GmbH
- Calon Cardio
- Jarvik Heart Inc.
- SynCardia Systems LLC
- Medtronic
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.